This year’s 340B Winter Conference was bursting at the seams with attendees. There were over 1,630 registrants for the conference representing a 12% growth over last year’s numbers. It was standing room only in the “340B Lessons from the Field” sessions led by many of our covered entity partners. In fact, there is so much […]
Once a prescription is written - just one part of the brand adoption challenge - pharmaceutical manufacturers are limited in their ability to influence patient compliance and persistence. For years, pharma manufacturers have struggled to influence change in the 20-30 percent of prescriptions that never get filled and the estimated 50 percent of patients who […]
February 5, 2018 (Gainesville, FL) – Curant Health was named to the University of Florida’s 2018 Gator100 during a ceremony February 2 at the University’s J. Wayne Reitz Union Grand Ballroom. Sponsored by the UF Alumni Association, in partnership with the UF Entrepreneurship & Innovation Center, the Gator100 recognizes the 100 fastest-growing businesses owned or […]
January 30, 2018 – Curant Health Director of Clinical Services, Vickie Andros, PharmD, and Senior Director of Commercial Strategy & Performance, Jake Caines, in PharmExec.com. Building awareness for life-changing pharmaceutical therapies is a primary focus of the brand team and is an activity at which brand teams are extremely adept. However, investments in activities that successfully […]
Jan 25, 2018 - Marc O'Connor, Curant Health COO in PharmExec.com It was widely reported in early January 2018 that, for the first time in history, healthcare became the United States’ largest source of jobs, surpassing the manufacturing and retail sectors. For many, the surprise was not that it happened, but that it happened so […]
January 16, 2018 (Atlanta, GA) - In Q4 2017, Curant Health added four new partners to its family of 340B covered entities it serves through its personalized medication management and specialty pharmacy fulfillment services. It also expanded its relationship with Chattanooga Cares to provide PrEP therapy for HIV-negative patients. The four new partners who will […]
Now more than ever, 340B covered entities must ensure they are providing high value, critical care for underserved populations in a way that stands up to scrutiny. What will we learn at 340B Winter 2018?
January 12, 2018 - Curant Health Director of Clinical Services, Vickie Andros, PharmD, and Senior Director of Commercial Strategy & Performance, Jake Caines, in PharmExec.com Numerous strategies and tactics are implemented by pharmaceutical manufacturer brand teams to drive awareness. According to Kantar Media, pharmaceutical advertising exceeded $6 billion in 2016. However, value for pharma organizations […]
What pharma can’t say about outcomes based contracts at JPMorgan 2018. Hint: It’s the “P” word.
December 12, 2017 - Curant Health COO Marc O'Connor in Becker’s Hospital Review Senior leadership of integrated delivery networks and health systems believe there is value in in-house specialty pharmacy, based on numerous, ongoing attempts to create their own. According to Adam Fein, 47% of hospitals with more than 600 beds operated a specialty pharmacy […]
